Skip to main content
Erschienen in: International Urology and Nephrology 2/2013

01.04.2013 | Nephrology - Original Paper

Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation

verfasst von: Andy K. H. Lim, Donald A. Campbell

Erschienen in: International Urology and Nephrology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background and objectives

Warfarin-related nephropathy is reported to occur with an INR >3.0 as a result of glomerular bleeding. There is a lack of prospective studies examining the effect of supratherapeutic warfarin anticoagulation on haematuria and acute kidney injury (AKI). Older patients may be susceptible due to greater warfarin use, prevalence of kidney disease and comorbidities. The objective of this study was to determine the incidence and nature of haematuria and AKI in older patients on warfarin and to determine any association with high INR levels.

Design, setting, participants and measurements

This was a prospective, observational study of 150 elderly patients receiving warfarin anticoagulation who were acutely hospitalised in a tertiary hospital. AKI was assessed using RIFLE criteria. Urinalysis was performed to quantify haematuria, characterise erythrocyte morphology and measure the albumin–creatinine ratio. Positive cases received follow-up at 4–6 weeks to determine resolution.

Results

An INR >3.0 was found in 54 % of patients. Pre-admission antibiotic use increased the risk of excessive anticoagulation. The incidence of isolated AKI, isolated haematuria and both was 18.7, 13.3 and 12 %, respectively. Factors associated with a higher risk of haematuria were an INR >4.0, non-urinary infection, catheterisation and albuminuria. Most cases of AKI were mild, and there was no demonstrable correlation between the admission INR and AKI. Admission with heart failure was significantly associated with an increased risk of persistent kidney impairment at follow-up.

Conclusions

Supratherapeutic warfarin anticoagulation was associated with an increased risk of haematuria, but not with AKI. The majority of cases of haematuria were transient.
Literatur
1.
Zurück zum Zitat Brodsky SV, Satoskar A, Chen J et al (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126PubMedCrossRef Brodsky SV, Satoskar A, Chen J et al (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126PubMedCrossRef
2.
Zurück zum Zitat Moreno JA, Martin-Cleary C, Gutierrez E et al (2012) AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol 7(1):175–184PubMedCrossRef Moreno JA, Martin-Cleary C, Gutierrez E et al (2012) AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol 7(1):175–184PubMedCrossRef
3.
Zurück zum Zitat Ware K, Brodsky P, Satoskar AA et al (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862PubMedCrossRef Ware K, Brodsky P, Satoskar AA et al (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862PubMedCrossRef
4.
Zurück zum Zitat Ozcan A, Ware K, Calomeni E et al (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364PubMedCrossRef Ozcan A, Ware K, Calomeni E et al (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364PubMedCrossRef
5.
Zurück zum Zitat Brodsky SV, Collins M, Park E et al (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146PubMedCrossRef Brodsky SV, Collins M, Park E et al (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146PubMedCrossRef
6.
Zurück zum Zitat Brodsky SV, Nadasdy T, Rovin BH et al (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189PubMedCrossRef Brodsky SV, Nadasdy T, Rovin BH et al (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189PubMedCrossRef
7.
Zurück zum Zitat Brodsky SV, Rovin BH, Hebert LA (2012) Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide. Nephrol Dial Transplant 27(2):475–477PubMedCrossRef Brodsky SV, Rovin BH, Hebert LA (2012) Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide. Nephrol Dial Transplant 27(2):475–477PubMedCrossRef
8.
Zurück zum Zitat Limdi NA, Beasley TM, Baird MF et al (2009) Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 20(4):912–921PubMedCrossRef Limdi NA, Beasley TM, Baird MF et al (2009) Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 20(4):912–921PubMedCrossRef
9.
Zurück zum Zitat Kleinow ME, Garwood CL, Clemente JL, Whittaker P (2011) Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic. J Manag Care Pharm 17(7):523–530PubMed Kleinow ME, Garwood CL, Clemente JL, Whittaker P (2011) Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic. J Manag Care Pharm 17(7):523–530PubMed
10.
Zurück zum Zitat Mathew TH, Johnson DW, Jones GR (2007) Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 187(8):459–463PubMed Mathew TH, Johnson DW, Jones GR (2007) Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 187(8):459–463PubMed
11.
Zurück zum Zitat Ricci Z, Cruz D, Ronco C (2008) The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 73(5):538–546PubMedCrossRef Ricci Z, Cruz D, Ronco C (2008) The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 73(5):538–546PubMedCrossRef
12.
Zurück zum Zitat Baillargeon J, Holmes HM, Lin YL et al (2012) Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med 125(2):183–189PubMedCrossRef Baillargeon J, Holmes HM, Lin YL et al (2012) Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med 125(2):183–189PubMedCrossRef
13.
Zurück zum Zitat Glasheen JJ, Fugit RV, Prochazka AV (2005) The risk of over anticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med 20(7):653–656PubMedCrossRef Glasheen JJ, Fugit RV, Prochazka AV (2005) The risk of over anticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med 20(7):653–656PubMedCrossRef
14.
Zurück zum Zitat Gutierrez E, Gonzalez E, Hernandez E et al (2007) Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol 2(1):51–57PubMedCrossRef Gutierrez E, Gonzalez E, Hernandez E et al (2007) Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol 2(1):51–57PubMedCrossRef
15.
Zurück zum Zitat Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10(2):188–195PubMedCrossRef Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10(2):188–195PubMedCrossRef
16.
Zurück zum Zitat Freda BJ, Slawsky M, Mallidi J, Braden GL (2011) Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis 58(6):1005–1017PubMedCrossRef Freda BJ, Slawsky M, Mallidi J, Braden GL (2011) Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis 58(6):1005–1017PubMedCrossRef
17.
Zurück zum Zitat Johnson SG, Rogers K, Delate T, Witt DM (2008) Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 133(4):948–954PubMedCrossRef Johnson SG, Rogers K, Delate T, Witt DM (2008) Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 133(4):948–954PubMedCrossRef
18.
Zurück zum Zitat Douketis JD (2011) Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why? Thromb Res 127(6):513–517PubMedCrossRef Douketis JD (2011) Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why? Thromb Res 127(6):513–517PubMedCrossRef
Metadaten
Titel
Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation
verfasst von
Andy K. H. Lim
Donald A. Campbell
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2013
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0364-0

Weitere Artikel der Ausgabe 2/2013

International Urology and Nephrology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.